Section 6 of 6
References
119 sources
- ADARx Pharmaceuticals (opens in a new tab)
- ADARx Pharmaceuticals (2023) (opens in a new tab)
- ADARx Pharmaceuticals (2025) (opens in a new tab)
- ADARx Pharmaceuticals Fast Track designation announcement (2026) (opens in a new tab)
- ADARx Pharmaceuticals Form 10-Q (2026) (opens in a new tab)
- ADARx Pharmaceuticals onvuzosiran data announcement (2026) (opens in a new tab)
- ADARx Pharmaceuticals presentation (2026) (opens in a new tab)
- ADARx Pharmaceuticals prospectus (2026) (opens in a new tab)
- ADARx Pharmaceuticals third quarter 2026 results announcement (2026) (opens in a new tab)
- Argo Biopharma (2026) (opens in a new tab)
- Arora et al. (2023) (opens in a new tab)
- Banerji et al. (2018) (opens in a new tab)
- Beard et al. (2022) (opens in a new tab)
- Betschel et al. (2026) (opens in a new tab)
- BioCryst Pharmaceuticals (2026) (opens in a new tab)
- BioCryst Pharmaceuticals Colorado WAC disclosure (2026) (opens in a new tab)
- Bork et al. (2006) (opens in a new tab)
- Bork et al. (2012) (opens in a new tab)
- Broderick et al. (2025) (opens in a new tab)
- Busse et al. (2021) (opens in a new tab)
- Busse et al. (2026) (opens in a new tab)
- Caballero et al. (2026) (opens in a new tab)
- Cancian et al. (2026a) (opens in a new tab)
- Cancian et al. (2026b) (opens in a new tab)
- Castaldo et al. (2021) (opens in a new tab)
- Castaldo et al. (2025) (opens in a new tab)
- Christiansen et al. (2023) (opens in a new tab)
- ClinicalTrials.gov NCT05139810 (opens in a new tab)
- ClinicalTrials.gov NCT05392114 (opens in a new tab)
- ClinicalTrials.gov NCT05691361 (opens in a new tab)
- ClinicalTrials.gov NCT06960213 (opens in a new tab)
- ClinicalTrials.gov NCT07428499 (opens in a new tab)
- CMS Clinical Laboratory Fee Schedule (2026) (opens in a new tab)
- CMS Medicare Part B payment limit file (2026) (opens in a new tab)
- CMS Medicare Part D Spending by Drug (2026) (opens in a new tab)
- Craig et al. (2023) (opens in a new tab)
- Craig et al. (2026) (opens in a new tab)
- CSL (2023) (opens in a new tab)
- CSL Behring (2022) (opens in a new tab)
- CSL Behring (2026) (opens in a new tab)
- Danielsson et al. (2025) (opens in a new tab)
- Datta et al. (2026) (opens in a new tab)
- Department of Veterans Affairs Federal Supply Schedule pharmaceutical prices (2026) (opens in a new tab)
- EU Clinical Trials Register 2013-000916-10 (opens in a new tab)
- Farkas et al. (2026) (opens in a new tab)
- FDA (2018) (opens in a new tab)
- FDA (2020) (opens in a new tab)
- FDA (2022) (opens in a new tab)
- FDA ANDEMBRY prescribing information (2025) (opens in a new tab)
- FDA DAWNZERA prescribing information (2025) (opens in a new tab)
- FDA Drug Trials Snapshot ANDEMBRY (2025) (opens in a new tab)
- FDA Drug Trials Snapshot DAWNZERA (opens in a new tab)
- FDA Drug Trials Snapshot EKTERLY (opens in a new tab)
- FDA ORLADEYO prescribing information (2026) (opens in a new tab)
- FDA TAKHZYRO prescribing information (2026) (opens in a new tab)
- Feld et al. (2026) (opens in a new tab)
- Fisch et al. (2025) (opens in a new tab)
- Grover et al. (2022) (opens in a new tab)
- Guan et al. (2024) (opens in a new tab)
- Health Research Authority (2025) (opens in a new tab)
- Health Research Authority (2026) (opens in a new tab)
- Henao et al. (2016) (opens in a new tab)
- ICER (2021) (opens in a new tab)
- ICER final evidence report (2018) (opens in a new tab)
- Intellia Therapeutics (2025) (opens in a new tab)
- Intellia Therapeutics (2026) (opens in a new tab)
- Intellia Therapeutics AAAAI poster (2026) (opens in a new tab)
- Intellia Therapeutics investor presentation (2024) (opens in a new tab)
- Ionis Pharmaceuticals protocol and statistical analysis plan (2023) (opens in a new tab)
- KalVista Pharmaceuticals Colorado WAC disclosure (2026) (opens in a new tab)
- Khalid and Hitch (2025) (opens in a new tab)
- Kiani-Alikhan et al. (2024) (opens in a new tab)
- Kim et al. (2014) (opens in a new tab)
- Kutrieb et al. (2026) (opens in a new tab)
- Li et al. (2026) (opens in a new tab)
- Longhurst et al. (2017) (opens in a new tab)
- Lumry et al. (2010) (opens in a new tab)
- Lumry et al. (2018) (opens in a new tab)
- Lumry et al. (2021) (opens in a new tab)
- Lumry et al. (2026) (opens in a new tab)
- Maurer et al. (2022) (opens in a new tab)
- MedlinePlus (opens in a new tab)
- Minafra et al. (2022a) (opens in a new tab)
- Minafra et al. (2022b) (opens in a new tab)
- MO HealthNet Andembry fact blast (2025) (opens in a new tab)
- MO HealthNet Dawnzera fact blast (2025) (opens in a new tab)
- Murai et al. (2026) (opens in a new tab)
- NICE (2026) (opens in a new tab)
- Olson et al. (2026) (opens in a new tab)
- Pharvaris (2026) (opens in a new tab)
- Princic et al. (2025) (opens in a new tab)
- Riedl et al. (2024a) (opens in a new tab)
- Riedl et al. (2024b) (opens in a new tab)
- Riedl et al. (2025) (opens in a new tab)
- Riedl et al. (2026a) (opens in a new tab)
- Riedl et al. (2026b) (opens in a new tab)
- Sandberg et al. (2024) (opens in a new tab)
- Santé.fr (2026) (opens in a new tab)
- Shah et al. (2023) (opens in a new tab)
- Singh et al. (2025) (opens in a new tab)
- Smith et al. (2023) (opens in a new tab)
- Staubach et al. (2025) (opens in a new tab)
- Sundler Björkman et al. (2022) (opens in a new tab)
- Tachdjian et al. (2026) (opens in a new tab)
- Uminski et al. (2025) (opens in a new tab)
- US Hereditary Angioedema Association (opens in a new tab)
- Vanya et al. (2023) (opens in a new tab)
- Vázquez et al. (2026) (opens in a new tab)
- Villa et al. (2026) (opens in a new tab)
- Walsh et al. (2025) (opens in a new tab)
- Watt et al. (2023) (opens in a new tab)
- Watt et al. (2026) (opens in a new tab)
- Weller et al. (2016) (opens in a new tab)
- Weller et al. (2020) (opens in a new tab)
- Wilson et al. (2010) (opens in a new tab)
- Wong et al. (2025) (opens in a new tab)
- World Health Organization (2024) (opens in a new tab)
- Zuraw et al. (2021) (opens in a new tab)
- Zuraw et al. (2025) (opens in a new tab)